Consensus Analyst Roundup on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), International Business Machines Corporation (NYSE:IBM)

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) shares have a current ABR (average broker recommendation) of 2.22. This recommendation is offered by Zacks Research. The rating lands on a sliding numerical scale from 1 to 5. A recommendation of 5 would indicate a Strong Sell, and a 1 would signify a Strong Buy. The mean rating may help provide a general sense of analyst sentiment on company shares.

Sell-side analysts taken into consideration by Zacks have also provided price target estimates on shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). The highest current target is $598. The lowest price target out of the polled analysts is presently $350. The consensus target price is currently noted at $425.642. Analysts may employ various techniques to help predict future stock price levels.

On the earnings front, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is expected to post quarterly earnings per share of $2.5. This is the current consensus figure provided by Zacks. Investors and analysts will be looking for the company to next post earnings on or around 2017-05-04. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) most recently reported quarterly EPS of $2.19 for the quarter ending 2016-12-31. The gap between the actual and the projected estimate leading up to earnings created a surprise factor of -12.75%.

International Business Machines Corporation (NYSE:IBM) shares have a current ABR (average broker recommendation) of 2.76. This recommendation is offered by Zacks Research. The rating lands on a sliding numerical scale from 1 to 5. A recommendation of 5 would indicate a Strong Sell, and a 1 would signify a Strong Buy. The mean rating may help provide a general sense of analyst sentiment on company shares.

Sell-side analysts taken into consideration by Zacks have also provided price target estimates on shares of International Business Machines Corporation (NYSE:IBM). The highest current target is $215. The lowest price target out of the polled analysts is presently $135. The consensus target price is currently noted at $170.857. Analysts may employ various techniques to help predict future stock price levels.

On the earnings front, International Business Machines Corporation (NYSE:IBM) is expected to post quarterly earnings per share of $2.34. This is the current consensus figure provided by Zacks. Investors and analysts will be looking for the company to next post earnings on or around 2017-04-17. International Business Machines Corporation (NYSE:IBM) most recently reported quarterly EPS of $5.01 for the quarter ending 2016-12-31. The gap between the actual and the projected estimate leading up to earnings created a surprise factor of 2.45%.

Leave a Comment